In a zebrafish biomedical model of human Allan-Herndon-Dudley syndrome impaired MTH signaling leads to decreased neural cell diversity
- 1Centre for Marine Sciences of the University of the Algarve, Faro, Portugal
- 2Algarve Biomedical Center-Research Institute, University of the Algarve, Faro, Portugal
- 3Faculty of Medicine and Biomedical Sciences, University of the Algarve, Faro, Portugal
A corrigendum on
In a zebrafish biomedical model of human Allan-Herndon-Dudley syndrome impaired MTH signaling leads to decreased neural cell diversity
by Silva N and Campinho MA (2023) Front. Endocrinol. 14:1157685. doi: 10.3389/fendo.2023.1157685
In the published article, the Funding statement was missing. The correct Funding statement appears below.
“This study received Portuguese national funds from FCT - Foundation for Science and Technology through project PTDC/EXPL/MAR-BIO/0430/2013 and FCT UIDB/04326/2020 COMPETE 2020, through project EMBRC.PT ALG-01-0145-FEDER-022121. ABC-RI CRESC Algarve 2020. NS was a recipient of an FCT Ph.D. grant SFRH/BD/111226/2015. MC received an FCT-IF Starting Grant (IF/01274/2014). Support of ABC and Camara Municipal de Loulé”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: maternal thyroid hormone, monocarboxylic acid transporter 8, neurodevelopment, spinal cord, zebrafish, Allan-Herndon-Dudley syndrome (AHDS)
Citation: Silva N and Campinho MA (2023) Corrigendum: In a zebrafish biomedical model of human Allan-Herndon-Dudley syndrome impaired MTH signaling leads to decreased neural cell diversity. Front. Endocrinol. 14:1228183. doi: 10.3389/fendo.2023.1228183
Received: 24 May 2023; Accepted: 25 May 2023;
Published: 31 May 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Silva and Campinho. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marco António Campinho, macampinho@ualg.pt